Meeting Coverage:

American Academy of Ophthalmology

AAO: 2015

A Novel IOL Implant

Show Description +

Mark Kontos, MD, asks Louis D. “Skip” Nichamin, MD, about his study on a new accommodating IOL. The three-dimensional lens is a hydrophobic acrylic body filled with silicone oil, which Dr. Nichamin thinks could be the most novel IOL implant he has seen, citing data that spans 24 months.

Posted: 11/16/2015

Up Next

Placing iStents: Potential Challenges

Steven Sarkisian, MD, Steven Vold, MD


Advances With 24-Hour IOP Monitoring

Kaweh Mansouri, MD, Ranna Jaraha

New Technique for Lens Rescue

Jonathan L. Prenner, MD, Richard S. Kaiser, MD

Role-Playing: Difficult Scenarios

Christopher Starr, MD, Neda Shamie, MD

Phakic IOLs: What's Now, What's Next

Allon Barsam, MB, BS, MA, FRCOphth, Ranna Jaraha

Predictive Modeling for Lens Position

John Davidson, MD, Joseph J.K. Ma, MD, FRCSC

PVR Prevention: Identifying High-Risk Features

Jonathan L. Prenner, MD, Richard S. Kaiser, MD

Protocol S

Jeffrey Gross, MD, Scott Krzywonos

Anti-VEGF with Targeted PRP

David M. Brown, MD, Jonathan L. Prenner, MD

Optimum Timing: Pars Plana Vitrectomy

Caroline Baumal, MD , Richard Kaiser, MD

YAG Rates: Femto vs Phaco

Dan B. Tran, MD, Sonia Manning, MD

An Important Diagnosis: Conjunctival Melanoma

Carol L. Shields, MD, Mark Kontos, MD

Cross-Linking for Keratoconus

Parag Majmudar MD, Terry Kim, MD

A Novel IOL Implant

Mark Kontos, MD, asks Louis D. “Skip” Nichamin, MD, about his study on a new accommodating IOL. The three-dimensional lens is a hydrophobic acrylic body filled with silicone oil, which Dr. Nichamin thinks could be the most novel IOL implant he has seen, citing data that spans 24 months.

Posted: 11/16/2015


Please log in to leave a comment.

Comments

niveditha narayanan

10 years ago

Is it foldable iol that can be inseted through 2.2 mm incision?

Steven Hantman

10 years ago

Looking forward to seeing this lens!

More From AAO: 2015 Coverage

Protocol S

Jeffrey Gross, MD, Scott Krzywonos

Anti-VEGF with Targeted PRP

David M. Brown, MD, Jonathan L. Prenner, MD

Optimum Timing: Pars Plana Vitrectomy

Caroline Baumal, MD , Richard Kaiser, MD